Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer
Home
>
News
>
Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer
Print
Oligomerix
>
News
>
Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer
Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer
Post navigation
Previous Post
Oligomerix Announces Appointment of Robert Foerster, Former Pfizer Executive, as Chief Financial Officer
Next Post
Oligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-Association
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
